Showing results (101-110 of 5,040) with videos related to
Sort By:
Pageof 504
Multiple Sclerosis and Related Disorders|April 17, 2022
Effect of dual-task training on cognitive functions in persons with multiple sclerosis: A systematic review and meta-analysisZuhal Abasıyanık, Turhan KahramanMultiple Sclerosis and Related Disorders|May 4, 2022
Short report: Real-life analysis of the occurrence of persistent, transient, and fluctuating positive titres of neutralizing anti-drug antibodies in multiple sclerosis patients treated with interferon betaMatilde Oviedo Querejazu, Nicky Dunn, Ryan Ramanujam, et al.Multiple Sclerosis and Related Disorders|October 11, 2021
Retinal microvascular and neuronal function in patients with multiple sclerosis: 2-year follow-upQi Chen, Min Fang, Shahnaz Miri, et al.Multiple Sclerosis and Related Disorders|October 11, 2021
Follow-up after infectious mononucleosis in search of serological similarities with presymptomatic multiple sclerosisDaniel Jons, Linn Persson Berg, Peter Sundström, et al.Multiple Sclerosis and Related Disorders|October 6, 2021
UK variance in DMT advice and prescribing in MS and pregnancy: Impact of the UK consensus on pregnancy in multiple sclerosis ABN guidelinesCharmaine Yam, David Rog, Helen Ford, et al.Multiple Sclerosis and Related Disorders|January 29, 2022
Pregnancy outcomes following maternal or paternal exposure to teriflunomide in the Danish MS populationJohanna Balslev Andersen, Malthe Faurschou Wandall-Holm, Melinda MagyariMultiple Sclerosis and Related Disorders|January 30, 2022
Emotional processing intervention (EMOPRINT): A blinded randomized control trial to treat facial affect recognition deficits in multiple sclerosisHelen M Genova, Katie Lancaster, Zuzanna Myszko, et al.Multiple Sclerosis and Related Disorders|October 12, 2021
Predictors of cognitive fatigue and fatigability in multiple sclerosisLeila Mackay, Andrew M Johnson, Sheila T Moodie, et al.Multiple Sclerosis and Related Disorders|January 25, 2022
Pediatric neuromyelitis optica spectrum disorders in Portugal: A multicentre retrospective studyCecília Martins, João Moura, Sónia Figueiroa, et al.Multiple Sclerosis and Related Disorders|September 28, 2021
ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trialMaria Petracca, Mario Quarantelli, Marcello Moccia, et al.Pageof 504